Nestadt Paul S, Bohnert Amy S B
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, and Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore (Nestadt); Department of Psychiatry, University of Michigan, and U.S. Department of Veterans Affairs, Ann Arbor, Michigan (Bohnert).
Focus (Am Psychiatr Publ). 2020 Apr;18(2):100-105. doi: 10.1176/appi.focus.20200003. Epub 2020 Apr 23.
Psychiatrists are on the front lines of two simultaneous public health crises: the increasing rates of suicide and opioid-related deaths. In this review, the authors discuss ways in which these two classes of preventable deaths may be linked, with an emphasis on identifying and preventing both outcomes through increased understanding of their shared risk factors. As clinicians, it is crucial to maintain awareness of the ways in which opioid use may contribute to depression and suicidality, as well as how mood disorders may complicate opioid use. In light of this interplay, interventions which target risk factors for both suicide and overdose are key. Interventions include early treatment of substance dependence and depression, as well as harm reduction measures, such as provision of naloxone, medication-assisted treatments for dependency, and multidisciplinary approaches to chronic pain that do not rely solely on escalating opioid doses. It is also important to address social determinants of health, which may increase risk for both accidental and intentional overdose. The roads to overdose and suicide overlap considerably and cannot be considered separately.
自杀率和阿片类药物相关死亡率不断上升。在这篇综述中,作者讨论了这两类可预防死亡可能存在关联的方式,重点是通过加深对共同风险因素的理解来识别和预防这两种结果。作为临床医生,至关重要的是要意识到阿片类药物的使用可能导致抑郁和自杀倾向的方式,以及情绪障碍如何使阿片类药物的使用复杂化。鉴于这种相互作用,针对自杀和过量用药风险因素的干预措施至关重要。干预措施包括对物质依赖和抑郁症的早期治疗,以及减少伤害的措施,如提供纳洛酮、针对成瘾的药物辅助治疗,以及不单纯依赖增加阿片类药物剂量的慢性疼痛多学科治疗方法。解决健康的社会决定因素也很重要,这可能会增加意外和故意过量用药的风险。过量用药和自杀的途径有很大重叠,不能分开考虑。